$GILD Recent News The Nasdaq has a message to de
Post# of 89344
Posted On: 03/20/2014 9:51:33 PM
$GILD Recent News
The Nasdaq has a message to deliver 1:56 p.m. Today - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:15 p.m. March 14, 2014 - Saumya Vaishampayan
S&P 500 marks 50th record close; Nasdaq slips as biotechs reverse: Stock market live blog (recap) 4:38 p.m. March 6, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Read This Twitter Chat About Gilead and the Cost of its Hep C Drug 5:54 p.m. Today - TheStreet.com
Fate Reports In-Line Loss in Q4 - Analyst Blog 2:28 p.m. Today - Zacks.com
Prothena Surges on Clinical Data Hopes - Analyst Blog 11:00 a.m. Today - Zacks.com
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura 10:25 a.m. Today - Investors Business Daily
Palatin Technologies (PTN) Worth Watching: Stock Soars 15.6% - Tale of the Tape 9:25 a.m. Today - Zacks.com
Why ANI Pharmaceuticals (ANIP) Has a Bright Short-Term Future? - Tale of the Tape 8:45 a.m. Today - Zacks.com
Idenix Files Lawsuit vs. Gilead Again - Analyst Blog 5:25 p.m. March 19, 2014 - Zacks.com
Gilead's HCV Challengers Near The Starting Gate 4:28 p.m. March 19, 2014 - Investors Business Daily
Medivation-Astellas Seek Xtandi Label Expansion - Analyst Blog 4:20 p.m. March 19, 2014 - Zacks.com
Biogen Faces Delay in FDA Action Date - Analyst Blog 1:50 p.m. March 19, 2014 - Zacks.com
Stock Market News for March 19, 2014 - Market News 10:06 a.m. March 19, 2014 - Zacks.com
Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher - Tale of the Tape 9:46 a.m. March 19, 2014 - Zacks.com
Veteran Investor's Top Biotech and Drug Stocks 7:57 a.m. March 19, 2014 - Barrons.com
Gilead's HCV Challengers Near The Starting Gate 7:02 a.m. March 19, 2014 - Investors Business Daily
Jim Cramer's 'Mad Money' Recap: Profits Still Matter 8:07 p.m. March 18, 2014 - TheStreet.com
Actelion's Tracleer Misses Primary Endpoint - Analyst Blog 5:20 p.m. March 18, 2014 - Zacks.com
Repros Provides Proellex Update - Analyst Blog 5:10 p.m. March 18, 2014 - Zacks.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. March 18, 2014 - TheStreet.com
Intercept Sees Weakness in Earnings Result - Analyst Blog 4:45 p.m. March 18, 2014 - Zacks.com
Amgen Scores Again with PCSK9 Inhibitor - Analyst Blog 3:50 p.m. March 18, 2014 - Zacks.com
AHF: Gilead’s ‘Obscene’ $180M Payday for CEO Fuels Shareholder Resolution on Compensation 4:57 p.m. March 17, 2014 - BusinessWire - BZX
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:03 a.m. March 14, 2014 - GlobeNewswire
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:01 a.m. March 14, 2014 - Thomson Reuters ONE
Investor-Edge.com Most Active Equities Watch List: Staples, Gilead Sciences, Office Depot, and Sprint 8:00 a.m. March 7, 2014 - PR Newswire - PRF
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
The Nasdaq has a message to deliver 1:56 p.m. Today - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:15 p.m. March 14, 2014 - Saumya Vaishampayan
S&P 500 marks 50th record close; Nasdaq slips as biotechs reverse: Stock market live blog (recap) 4:38 p.m. March 6, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Read This Twitter Chat About Gilead and the Cost of its Hep C Drug 5:54 p.m. Today - TheStreet.com
Fate Reports In-Line Loss in Q4 - Analyst Blog 2:28 p.m. Today - Zacks.com
Prothena Surges on Clinical Data Hopes - Analyst Blog 11:00 a.m. Today - Zacks.com
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura 10:25 a.m. Today - Investors Business Daily
Palatin Technologies (PTN) Worth Watching: Stock Soars 15.6% - Tale of the Tape 9:25 a.m. Today - Zacks.com
Why ANI Pharmaceuticals (ANIP) Has a Bright Short-Term Future? - Tale of the Tape 8:45 a.m. Today - Zacks.com
Idenix Files Lawsuit vs. Gilead Again - Analyst Blog 5:25 p.m. March 19, 2014 - Zacks.com
Gilead's HCV Challengers Near The Starting Gate 4:28 p.m. March 19, 2014 - Investors Business Daily
Medivation-Astellas Seek Xtandi Label Expansion - Analyst Blog 4:20 p.m. March 19, 2014 - Zacks.com
Biogen Faces Delay in FDA Action Date - Analyst Blog 1:50 p.m. March 19, 2014 - Zacks.com
Stock Market News for March 19, 2014 - Market News 10:06 a.m. March 19, 2014 - Zacks.com
Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher - Tale of the Tape 9:46 a.m. March 19, 2014 - Zacks.com
Veteran Investor's Top Biotech and Drug Stocks 7:57 a.m. March 19, 2014 - Barrons.com
Gilead's HCV Challengers Near The Starting Gate 7:02 a.m. March 19, 2014 - Investors Business Daily
Jim Cramer's 'Mad Money' Recap: Profits Still Matter 8:07 p.m. March 18, 2014 - TheStreet.com
Actelion's Tracleer Misses Primary Endpoint - Analyst Blog 5:20 p.m. March 18, 2014 - Zacks.com
Repros Provides Proellex Update - Analyst Blog 5:10 p.m. March 18, 2014 - Zacks.com
Gilead Sciences Inc (GILD): Today's Featured Drugs Winner 5:00 p.m. March 18, 2014 - TheStreet.com
Intercept Sees Weakness in Earnings Result - Analyst Blog 4:45 p.m. March 18, 2014 - Zacks.com
Amgen Scores Again with PCSK9 Inhibitor - Analyst Blog 3:50 p.m. March 18, 2014 - Zacks.com
AHF: Gilead’s ‘Obscene’ $180M Payday for CEO Fuels Shareholder Resolution on Compensation 4:57 p.m. March 17, 2014 - BusinessWire - BZX
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:03 a.m. March 14, 2014 - GlobeNewswire
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:01 a.m. March 14, 2014 - Thomson Reuters ONE
Investor-Edge.com Most Active Equities Watch List: Staples, Gilead Sciences, Office Depot, and Sprint 8:00 a.m. March 7, 2014 - PR Newswire - PRF
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
(0)
(0)